Moderna net income 2016-2022

This statistic illustrates the annual net loss of Moderna Inc. between 2016 and 2022. Moderna became well-known for developing one of the very first COVID-19 vaccines to be approved for widely usage in 2020. The company recorded a net loss of 747 million U.S. dollars in 2020. But in 2021, the net income reached 12.2 billion U.S. dollars.